Sichong Han obtained a Ph.D. in Chemical Engineering and Technology from Beijing University of Chemical Technology, and her research centers on the phenotypes and mechanisms of CAR-T therapy for lymphoma autoimmune diseases now. In spare time, She likes reading suspense novels.